Compare PLTK & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLTK | CYRX |
|---|---|---|
| Founded | 2010 | 1999 |
| Country | Israel | United States |
| Employees | N/A | 1100 |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 812.4M | 814.9M |
| IPO Year | 2020 | 2008 |
| Metric | PLTK | CYRX |
|---|---|---|
| Price | $2.05 | $16.64 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 9 |
| Target Price | $4.72 | ★ $19.78 |
| AVG Volume (30 Days) | ★ 959.9K | 633.3K |
| Earning Date | 11-05-2026 | 11-03-2026 |
| Dividend Yield | ★ 4.57% | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,755,400,000.00 | $176,177,000.00 |
| Revenue This Year | $0.90 | $10.96 |
| Revenue Next Year | $0.01 | $10.10 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 8.08 | N/A |
| 52 Week Low | $2.07 | $7.61 |
| 52 Week High | $4.42 | $18.36 |
| Indicator | PLTK | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 33.27 | 47.55 |
| Support Level | N/A | $14.55 |
| Resistance Level | $2.98 | $16.87 |
| Average True Range (ATR) | 0.08 | 0.56 |
| MACD | 0.01 | -0.13 |
| Stochastic Oscillator | 1.67 | 10.83 |
Playtika Holding Corp is engaged in developing mobile games. Some of its games include Board Kings, House of Fun, Poker Heat, Slotomania, and Bingo Blitz. The company has built live game operations services and a proprietary technology platform to support its portfolio of games. It derives revenue from the sale of virtual items associated with online games. Geographically, the group has a business presence in the USA, EMEA, APAC, and Other regions of which key revenue is derived from the USA. The company offers both Mobile and Web-based platforms.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.